
Rebiwen 20gm Injection
Marketer
Gwenn Healthcare
Salt Composition
Rabeprazole (20gm)
Overview Rebiwen 20gm Injection
Acid-reducing injection Rebiwen (20gm) effectively lowers stomach acid production. It treats acid-related gastrointestinal disorders including reflux, indigestion, peptic ulcers, and other conditions stemming from excessive acid. This fast-acting injection offers rapid relief from acidity. Additionally, it prevents stress ulcers in critically ill patients and is pre-anesthetically administered to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), it's intravenously administered by a healthcare professional only when deemed more appropriate than oral medication. Dosage and treatment duration are determined by your physician based on your condition and response. Optimal results are achieved by adopting a diet of smaller, more frequent meals, while avoiding caffeine, spicy foods, and fatty meals. Common, typically mild, side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, abdominal pain, and thrombophlebitis (vein inflammation). Persistent or bothersome symptoms warrant medical attention. Prolonged use, particularly exceeding one year, may increase the risk of fractures, especially at higher doses. Discuss bone loss prevention strategies, such as calcium and vitamin D supplementation, with your doctor. Hypomagnesemia (low magnesium) has been reported in patients using this medication for three months or more, potentially causing fatigue, confusion, dizziness, muscle spasms, and arrhythmia. Your doctor may monitor magnesium levels. Rebiwen is unsuitable for individuals with severe liver disease, those on HIV medications, those with a history of PPI allergies, or those with osteoporosis. Pregnant or lactating individuals should seek medical counsel before use. Alcohol consumption should be avoided due to its acid-stimulating effect. Refrain from operating machinery if dizziness or drowsiness occurs.
Uses of Rebiwen 20gm Injection
Management of heartburn and peptic ulcers
Major Benefits of Rebiwen 20gm Injection:
Administering this medication will be handled by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Rebiwen 20gm Injection:
- Nausea
- Vomiting
- Headache
- Dizziness
- Flatulence
- Diarrhea
- Stomach pain
- Thrombophlebitis
How to use Rebiwen 20gm Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Rebiwen 20gm Injection works:
Stomach acid reduction is achieved by Rebiwen 20gm Injection, a proton pump inhibitor (PPI), providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Rebiwen 20gm Injection concurrently with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Rebiwen 20gm Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Administration of Rebiwen 20gm Injection while breastfeeding is likely inadvisable. Preliminary human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Rebiwen 20gm Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Rebiwen 20gm Injection poses no safety concerns for patients with renal impairment and requires no dosage modification.
LiverCAUTION
Patients with severe hepatic impairment should use Rebiwen 20gm Injection cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Rebiwen 20gm Injection :
Omitting a scheduled Rebiwen 20gm Injection necessitates contacting your physician.
Facts to Know About Rebiwen 20gm Injection
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Actions | Gastric acid suppressants |
